Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study

J Intern Med. 2021 Feb;289(2):259-263. doi: 10.1111/joim.13145. Epub 2020 Jul 17.
No abstract available

Keywords: COVID-19; SARS-CoV-2; methylprednisolone; survival; tocilizumab.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19*
  • China
  • Humans
  • Methylprednisolone
  • Pneumonia* / drug therapy
  • Respiratory Distress Syndrome*
  • Risk Factors
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab
  • Methylprednisolone